[go: up one dir, main page]

ZA200710193B - Stable emulsion composition - Google Patents

Stable emulsion composition

Info

Publication number
ZA200710193B
ZA200710193B ZA200710193A ZA200710193A ZA200710193B ZA 200710193 B ZA200710193 B ZA 200710193B ZA 200710193 A ZA200710193 A ZA 200710193A ZA 200710193 A ZA200710193 A ZA 200710193A ZA 200710193 B ZA200710193 B ZA 200710193B
Authority
ZA
South Africa
Prior art keywords
emulsion composition
stable emulsion
stable
composition
emulsion
Prior art date
Application number
ZA200710193A
Other languages
English (en)
Inventor
Asakawa Naoki
Doen Takayuki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37308111&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200710193(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of ZA200710193B publication Critical patent/ZA200710193B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA200710193A 2005-04-28 2006-04-27 Stable emulsion composition ZA200710193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005131807 2005-04-28

Publications (1)

Publication Number Publication Date
ZA200710193B true ZA200710193B (en) 2009-07-29

Family

ID=37308111

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200710193A ZA200710193B (en) 2005-04-28 2006-04-27 Stable emulsion composition

Country Status (24)

Country Link
US (1) US20100016381A1 (uk)
EP (2) EP1875926A4 (uk)
JP (2) JP5236287B2 (uk)
KR (1) KR101321633B1 (uk)
CN (2) CN101212986B (uk)
AR (1) AR054264A1 (uk)
AU (1) AU2006241671B2 (uk)
BR (1) BRPI0610029A2 (uk)
CA (1) CA2605773C (uk)
CR (2) CR9495A (uk)
GE (1) GEP20105031B (uk)
IL (1) IL186673A (uk)
MA (1) MA29487B1 (uk)
ME (1) MEP10209A (uk)
MX (1) MX2007013407A (uk)
MY (1) MY147790A (uk)
NO (1) NO20075985L (uk)
NZ (1) NZ563225A (uk)
PE (1) PE20061437A1 (uk)
RU (1) RU2428204C2 (uk)
TW (1) TWI462745B (uk)
UA (1) UA97346C2 (uk)
WO (1) WO2006118329A1 (uk)
ZA (1) ZA200710193B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2018855A1 (en) * 2006-05-15 2009-01-28 Takeda Pharmaceutical Company Limited Pharmaceutical agent
WO2008060934A2 (en) * 2006-11-14 2008-05-22 Acusphere, Inc. Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
CN101229174B (zh) * 2008-01-25 2010-12-15 广东一品红药业有限公司 一种含有盐酸依匹斯汀的抗过敏组合物
US7829513B2 (en) * 2009-03-12 2010-11-09 Greenology Products, Inc. Organic cleaning composition
PT2528598E (pt) 2010-01-27 2016-03-04 Takeda Pharmaceuticals Co Compostos para suprimir um distúrbio do nervo periférico induzido por um agente anti-cancro
JP5894752B2 (ja) * 2011-03-31 2016-03-30 富士フイルム株式会社 プロスタグランジン含有脂肪乳剤
JP2012214430A (ja) * 2011-03-31 2012-11-08 Fujifilm Corp プロスタグランジン含有脂肪乳剤
BR112013025070A2 (pt) * 2011-03-31 2017-02-14 Fujifilm Corp emulsão graxa contendo prostaglandina
KR102200176B1 (ko) 2012-05-08 2021-01-11 에어로믹스, 인코포레이티드 신규 방법
AU2014346682B2 (en) * 2013-11-06 2020-03-12 Aeromics, Inc. Novel formulations
US20170246136A1 (en) * 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
US12076397B2 (en) 2016-05-10 2024-09-03 The Regents Of The University Of Michigan Emulsion adjuvant for intramuscular, intradermal and subcutaneous administration
WO2021252449A1 (en) * 2020-06-08 2021-12-16 Harm Reduction Therapeutics, Inc. Sterilized formulations

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128339A (en) * 1990-11-01 1992-07-07 Sterling Winthrop Inc. Proteolytic enzyme inhibition method
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
JP2836599B2 (ja) 1996-08-09 1998-12-14 日本電気株式会社 通信制御装置
KR100577044B1 (ko) * 1998-03-09 2006-05-08 다케다 야쿠힌 고교 가부시키가이샤 시클로알켄 유도체, 그의 제조 방법 및 용도
KR100362325B1 (ko) 1998-03-11 2002-11-23 미쓰비시덴키 가부시키가이샤 방전 표면 처리용 압분체 전극
KR100778256B1 (ko) * 1999-08-06 2007-11-27 다케다 야쿠힌 고교 가부시키가이샤 치환 방향환 화합물, 그의 제조법 및 용도
US6532316B1 (en) * 1999-11-10 2003-03-11 Avanex Corporation Bi-directional polarization-independent optical isolator
US7105572B2 (en) * 2000-02-04 2006-09-12 Takeda Pharmaceutical Company Limited Stable emulsion compositions
JP4863553B2 (ja) * 2000-02-04 2012-01-25 武田薬品工業株式会社 安定な乳化組成物
JP2003033195A (ja) * 2001-07-24 2003-02-04 Kyowa Hakko Kogyo Co Ltd テトラヒドロクルクミン類の製造方法
WO2003013513A1 (en) * 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Stable emulsion composition
US20030220284A1 (en) * 2002-02-22 2003-11-27 Patricia Yotnda Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
CA2508441A1 (en) * 2002-12-06 2004-06-24 Otsuka Pharmaceutical Factory, Inc. Propofol-containing fat emulsions
BRPI0415001A (pt) * 2003-10-03 2006-11-07 Ono Pharmaceutical Co droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
US20090062355A1 (en) * 2006-04-20 2009-03-05 Takeda Pharmaceutical Company Limited Pharmaceutical Product

Also Published As

Publication number Publication date
JP5236287B2 (ja) 2013-07-17
MY147790A (en) 2013-01-31
NZ563225A (en) 2011-01-28
EP1875926A4 (en) 2013-01-16
BRPI0610029A2 (pt) 2011-10-11
KR101321633B1 (ko) 2013-10-22
UA97346C2 (uk) 2012-02-10
CA2605773A1 (en) 2006-11-09
CN101212986A (zh) 2008-07-02
RU2428204C2 (ru) 2011-09-10
AU2006241671B2 (en) 2012-06-07
CN102670503A (zh) 2012-09-19
TW200724159A (en) 2007-07-01
MEP10209A (en) 2011-12-20
CA2605773C (en) 2014-04-08
MA29487B1 (fr) 2008-05-02
IL186673A (en) 2013-08-29
MX2007013407A (es) 2008-01-15
JPWO2006118329A1 (ja) 2008-12-18
PE20061437A1 (es) 2007-01-25
TWI462745B (zh) 2014-12-01
IL186673A0 (en) 2008-01-20
EP2255785A3 (en) 2013-01-16
CR9495A (es) 2008-02-22
RU2007144071A (ru) 2009-06-10
WO2006118329A1 (ja) 2006-11-09
US20100016381A1 (en) 2010-01-21
CR20130666A (es) 2014-03-13
EP2255785A2 (en) 2010-12-01
AR054264A1 (es) 2007-06-13
EP1875926A1 (en) 2008-01-09
NO20075985L (no) 2008-01-25
AU2006241671A1 (en) 2006-11-09
JP2013040215A (ja) 2013-02-28
GEP20105031B (en) 2010-06-25
KR20080011413A (ko) 2008-02-04
CN101212986B (zh) 2015-01-14

Similar Documents

Publication Publication Date Title
ZA200710193B (en) Stable emulsion composition
IL185906A0 (en) Composition
IL184421A0 (en) Fertilizer-compatible composition
PL3327109T3 (pl) Kompozycja
AP2008004547A0 (en) Petsticidal compositions
ZA200705428B (en) Stable prostaglandin-containing compositions
GB0618435D0 (en) Composition
IL186778A0 (en) Stabilized composition
EP1847249A4 (en) hair dye
IL197927A0 (en) W/o/w emulsion composition
IL190321A0 (en) Compositions containing saratin
ZA200705932B (en) Fertilizer-compatible composition
EP1947129A4 (en) PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION
GB0507167D0 (en) Composition
GB0508250D0 (en) Composition
GB0506044D0 (en) Composition
ZA200707917B (en) Composition
IL186274A0 (en) Fragrance composition
IL188062A0 (en) Fragrance composition
GB0502341D0 (en) Composition
GB0513641D0 (en) Anti-egeing composition
GB0510286D0 (en) Composition
GB0510596D0 (en) Composition
GB0523760D0 (en) Composition
GB0526395D0 (en) Composition